Chih-Ya Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chih-Ya Chang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Chiang Chang
Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital, School of Medicine, National Defense Medical University, Taipei, Taiwan
1 shared publication - Chi-Fu Chiang
Research & Design Center, TCI Co., Ltd., Taipei, Taiwan
1 shared publication - Chia-Huei Lin
Affiliations School of Nursing, National Defense Medical University, Taipei City, Taiwan, Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei City, Taiwan
1 shared publication - Chia-Ying Lai
Department of Physical Medicine and Rehabilitation School of Medicine, College of Medicine, National Defense Medical University Taipei Taiwan
1 shared publication - Chieh‐Yi Song
School of Nursing, College of Nursing National Defense Medical University Taipei Taiwan
1 shared publication - Chien-Yao Huang
Department of Physical Medicine and Rehabilitation School of Medicine, College of Medicine, National Defense Medical University Taipei Taiwan
1 shared publication
Latest Publications
- Open Access
- 15 May 2026
- Published by Medical Journals Sweden AB in Journal of Rehabilitation Medicine
- Vol. 58, jrm44901
Efficacy of ultrasound-guided intra-articular hyaluronic acid injection in the management of adhesive capsulitis: a randomized controlled trial
Objective: To compare the efficacy and safety of ultrasound-guided intra-articular hyaluronic acid injection versus supervised rehabilitation in patients with frozen-phase adhesive capsulitis. Design: Single-center, parallel-group, randomized controlled trial with 26-week follow-up. Subjects/Patients: Forty-six adults aged 40–70 years with clinically and radiologically confirmed frozen-phase adhesive capsulitis. Methods: Participants were randomly assigned to receive either three weekly ultrasound-guided intra-articular hyaluronic acid injections or supervised physical therapy twice weekly for six weeks. Outcomes assessed at baseline and at weeks 4, 6, 8, and 26 included the Shoulder Pain and Disability Index (SPADI) and shoulder range of motion. Results: Both groups achieved significant within-group improvements in SPADI and range of motion over 26 weeks (all p < 0.01 vs. baseline). No statistically significant between-group differences were observed in total SPADI or its pain and disability subscales at any follow-up time point (all p > 0.05). At week 26, the hyaluronic acid group’s mean total SPADI decreased from 43.0 ± 17.7 to 16.1 ± 12.8 (p < 0.01), while the rehabilitation group improved from 52.0 ± 18.4 to 23.2 ± 21.8 (p < 0.01). Pain subscores were reduced by 64.3% (hyaluronic acid) and 56.1% (rehabilitation); function subscores decreased by 60.9% and 54.8%, respectively (all p < 0.01). Both groups showed significant gains in active and passive flexion, abduction, and external rotation, without significant between-group differences (all p > 0.05). No treatment-related adverse events were observed. Conclusion: Ultrasound-guided hyaluronic acid injection and supervised rehabilitation produced comparable and clinically meaningful improvements in pain, function, and shoulder mobility in frozen-phase adhesive capsulitis.
- 15 May 2026
- Published by Medical Journals Sweden AB in Journal of Rehabilitation Medicine
- Vol. 58, jrm44901
Open AccessEfficacy of ultrasound-guided intra-articular hyaluronic acid injection in the management of adhesive capsulitis: a randomized controlled trial
Objective: To compare the efficacy and safety of ultrasound-guided intra-articular hyaluronic acid injection versus supervised rehabilitation in patients with frozen-phase adhesive capsulitis. Design: Single-center, parallel-group, randomized controlled trial with 26-week follow-up. Subjects/Patients: Forty-six adults aged 40–70 years with clinically and radiologically confirmed frozen-phase adhesive capsulitis. Methods: Participants were randomly assigned to receive either three weekly ultrasound-guided intra-articular hyaluronic acid injections or supervised physical therapy twice weekly for six weeks. Outcomes assessed at baseline and at weeks 4, 6, 8, and 26 included the Shoulder Pain and Disability Index (SPADI) and shoulder range of motion. Results: Both groups achieved significant within-group improvements in SPADI and range of motion over 26 weeks (all p < 0.01 vs. baseline). No statistically significant between-group differences were observed in total SPADI or its pain and disability subscales at any follow-up time point (all p > 0.05). At week 26, the hyaluronic acid group’s mean total SPADI decreased from 43.0 ± 17.7 to 16.1 ± 12.8 (p < 0.01), while the rehabilitation group improved from 52.0 ± 18.4 to 23.2 ± 21.8 (p < 0.01). Pain subscores were reduced by 64.3% (hyaluronic acid) and 56.1% (rehabilitation); function subscores decreased by 60.9% and 54.8%, respectively (all p < 0.01). Both groups showed significant gains in active and passive flexion, abduction, and external rotation, without significant between-group differences (all p > 0.05). No treatment-related adverse events were observed. Conclusion: Ultrasound-guided hyaluronic acid injection and supervised rehabilitation produced comparable and clinically meaningful improvements in pain, function, and shoulder mobility in frozen-phase adhesive capsulitis.
Factors associated with low anaerobic threshold and its impact on sleep quality and health‐related quality of life in individuals with long COVID
Introduction: Anaerobic threshold (AT), a crucial indicator of submaximal exercise capacity and cardiorespiratory function, has been reported to be impaired in individuals with long COVID. However, the predictors of reduced AT during exercise in this population and its impacts on patient‐reported outcomes, including sleep quality and health‐related quality of life (HRQL), remain unknown. This study aims to identify factors associated with low AT and examine its relationship with patient‐reported outcomes. Objective: To investigate the predictors of low AT and compare patient‐reported outcomes (sleep quality and HRQL) between individuals with normal and low AT among those with long COVID. Design: Cross‐sectional study. Setting: Post‐COVID integrated outpatient clinic at a medical center in northern Taiwan. Patients (or Participants): Eligible patients aged 20–80 years with long COVID were recruited. Interventions: Not applicable. Main Outcome Measure(s): AT, peak oxygen consumption (peak VO 2 ), and patient‐reported outcomes, including sleep quality and HRQL, assessed using the Taiwanese version of the World Health Organization Quality of Life‐BREF and Pittsburgh Sleep Quality Index. Results: Factors associated with low AT included younger age (odds ratio [OR] = 0.904, 95% confidence interval [CI]: 0.867–0.942, p < .001) and lower peak VO 2 (OR = 0.737, 95% CI: 0.659–0.842, p < .001). Participants with low AT exhibited impaired patient‐reported outcomes including poorer sleep quality ( p = .008), and lower HRQL scores across all domains, as compared to those with normal AT. After adjustment for significant covariates, only the psychological domain of HRQL remained statistically significant (adjusted p = .035). Conclusions: Low AT in individuals with long COVID was associated with younger age and lower peak VO 2 . Its independent impact on sleep quality and HRQL appears limited, suggesting that patient‐reported outcomes may be influenced by multiple interacting factors and warrant further investigation.
Factors associated with low anaerobic threshold and its impact on sleep quality and health‐related quality of life in individuals with long COVID
Introduction: Anaerobic threshold (AT), a crucial indicator of submaximal exercise capacity and cardiorespiratory function, has been reported to be impaired in individuals with long COVID. However, the predictors of reduced AT during exercise in this population and its impacts on patient‐reported outcomes, including sleep quality and health‐related quality of life (HRQL), remain unknown. This study aims to identify factors associated with low AT and examine its relationship with patient‐reported outcomes. Objective: To investigate the predictors of low AT and compare patient‐reported outcomes (sleep quality and HRQL) between individuals with normal and low AT among those with long COVID. Design: Cross‐sectional study. Setting: Post‐COVID integrated outpatient clinic at a medical center in northern Taiwan. Patients (or Participants): Eligible patients aged 20–80 years with long COVID were recruited. Interventions: Not applicable. Main Outcome Measure(s): AT, peak oxygen consumption (peak VO 2 ), and patient‐reported outcomes, including sleep quality and HRQL, assessed using the Taiwanese version of the World Health Organization Quality of Life‐BREF and Pittsburgh Sleep Quality Index. Results: Factors associated with low AT included younger age (odds ratio [OR] = 0.904, 95% confidence interval [CI]: 0.867–0.942, p < .001) and lower peak VO 2 (OR = 0.737, 95% CI: 0.659–0.842, p < .001). Participants with low AT exhibited impaired patient‐reported outcomes including poorer sleep quality ( p = .008), and lower HRQL scores across all domains, as compared to those with normal AT. After adjustment for significant covariates, only the psychological domain of HRQL remained statistically significant (adjusted p = .035). Conclusions: Low AT in individuals with long COVID was associated with younger age and lower peak VO 2 . Its independent impact on sleep quality and HRQL appears limited, suggesting that patient‐reported outcomes may be influenced by multiple interacting factors and warrant further investigation.